The FDA on Tuesday said it is planning on doing more surprise inspections of foreign factories, a day after Trump signed an ...

Marty Makary named Vinay Prasad as the next director of the Center for Biologics and Research, Endpoints News has learned.

Plus, news about Atara Bio­ther­a­peu­tics, Im­mutep, blue­bird bio, OSE Im­munother­a­peu­tics, Mer­sana Ther­a­peu­tics, ...

NewLimit raises $130M Series B led by Kleiner Perkins to advance epigenetic reprogramming research for liver disease ...

Aldeyra Therapeutics reports Phase 3 success with reproxalap for dry eye disease, plans third FDA filing after previous ...

Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy ...

PTC Therapeutics announced Monday that its splicing drug for Huntington’s disease met the primary endpoint of a Phase 2 study ...

Bristol Myers Squibb is letting go of 516 workers in New Jersey as part of a wide-reaching cost-cutting plan aimed at making ...

Function Health is buying Ezra in a bid to create a haven for people who want copious amounts of data on their bodies. The ...

Deerfield Management is back with its third healthcare venture fund, this time securing more than $600 million to create new ...

Topas Therapeutics reveals first data from celiac disease therapy study, showing promise in immune system retraining with ...

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.